🧫 Experiment Protocol
Exploratorychronic kidney diseaseACAT1ACAT1 knockdown with L-carnitine supplementationproposed
Rescue experiments using L-carnitine supplementation were conducted to validate the metabolic pathway downstream of ACAT1. After ACAT1 knockdown abolished hyperoside's benefits, L-carnitine was administered to determine if it could restore the metabolic flux and mitochondrial improvements. This experimental design tested whether the ACAT1-L-carnitine metabolic axis is crucial for hyperoside's mechanism of action. The results showed partial restoration of benefits, confirming the pathway's functional relevance and suggesting L-carnitine as a key metabolic intermediate.
PRIMARY OUTCOME
partial restoration of metabolic and mitochondrial benefits
EXPECTED OUTCOMES
L-carnitine would partially rescue the effects lost by ACAT1 knockdown
SUCCESS CRITERIA
measurable restoration of metabolic parameters and mitochondrial function
PROTOCOL
ACAT1 knockdown, L-carnitine supplementation, assessment of metabolic flux and mitochondrial function